These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15239666)

  • 1. 2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferase.
    Nelson ME; Loktionova NA; Pegg AE; Moschel RC
    J Med Chem; 2004 Jul; 47(15):3887-91. PubMed ID: 15239666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of O(6)-alkylguanine-DNA alkyltransferase by folate esters of O(6)-benzyl-2'-deoxyguanosine and of O(6)-[4-(hydroxymethyl)benzyl]guanine.
    Javanmard S; Loktionova NA; Fang Q; Pauly GT; Pegg AE; Moschel RC
    J Med Chem; 2007 Oct; 50(21):5193-201. PubMed ID: 17880193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
    Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient repair of O6-ethylguanine, but not O4-ethylthymine or O2-ethylthymine, is dependent upon O6-alkylguanine-DNA alkyltransferase and nucleotide excision repair activities in human cells.
    Bronstein SM; Skopek TR; Swenberg JA
    Cancer Res; 1992 Apr; 52(7):2008-11. PubMed ID: 1551130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine.
    Loktionova NA; Xu-Welliver M; Crone TM; Kanugula S; Pegg AE
    Biochem Pharmacol; 1999 Jul; 58(2):237-44. PubMed ID: 10423163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of the conserved residue tyrosine-158 to histidine renders human O6-alkylguanine-DNA alkyltransferase insensitive to the inhibitor O6-benzylguanine.
    Xu-Welliver M; Leitão J; Kanugula S; Pegg AE
    Cancer Res; 1999 Apr; 59(7):1514-9. PubMed ID: 10197622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased killing of prostate, breast, colon, and lung tumor cells by the combination of inactivators of O6-alkylguanine-DNA alkyltransferase and N,N'-bis(2-chloroethyl)-N-nitrosourea.
    Pegg AE; Swenn K; Chae MY; Dolan ME; Moschel RC
    Biochem Pharmacol; 1995 Oct; 50(8):1141-8. PubMed ID: 7488227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of the human O6-alkylguanine-DNA alkyltransferase containing arginine at codon 160 to inactivation by O6-benzylguanine.
    Edara S; Kanugula S; Goodtzova K; Pegg AE
    Cancer Res; 1996 Dec; 56(24):5571-5. PubMed ID: 8971155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.
    Cussac C; Rapp M; Mounetou E; Madelmont JC; Maurizis JC; Godeneche D; Dupuy JM; Sauzieres J; Baudry JP; Veyre A
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1353-8. PubMed ID: 7996446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-Substituted O6-benzylguanine, substituted 6(4)-(benzyloxy)pyrimidine, and related derivatives as inactivators of human O6-alkylguanine-DNA alkyltransferase.
    Chae MY; Swenn K; Kanugula S; Dolan ME; Pegg AE; Moschel RC
    J Med Chem; 1995 Jan; 38(2):359-65. PubMed ID: 7830279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
    Dolan ME; Chae MY; Pegg AE; Mullen JH; Friedman HS; Moschel RC
    Cancer Res; 1994 Oct; 54(19):5123-30. PubMed ID: 7923129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines.
    Behrsing HP; Furniss MJ; Robillard KA; Tomaszewski JE; Parchment RE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1083-91. PubMed ID: 19727731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of DNA on the inactivation of O6-alkylguanine-DNA alkyltransferase by 9-substituted O6-benzylguanine derivatives.
    Pegg AE; Chung L; Moschel RC
    Biochem Pharmacol; 1997 May; 53(10):1559-64. PubMed ID: 9260884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases.
    Dolan ME; Roy SK; Garbiras BJ; Helft P; Paras P; Chae MY; Moschel RC; Pegg AE
    Biochem Pharmacol; 1998 May; 55(10):1701-9. PubMed ID: 9634007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inactivation of human O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine.
    Pegg AE; Boosalis M; Samson L; Moschel RC; Byers TL; Swenn K; Dolan ME
    Biochemistry; 1993 Nov; 32(45):11998-2006. PubMed ID: 8218276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of purified human O6-alkylguanine-DNA alkyltransferase by alkylating agents or alkylated DNA.
    Brent TP
    Cancer Res; 1986 May; 46(5):2320-3. PubMed ID: 2938727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism in rats of 2,4-diamino-6-benzyloxy-5- nitrosopyrimidine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
    Roy SK; Moschel RC; Dolan ME
    Drug Metab Dispos; 1996 Nov; 24(11):1205-11. PubMed ID: 8937854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.
    Dolan ME; Moschel RC; Pegg AE
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5368-72. PubMed ID: 2164681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of bischloroethylnitrosourea-induced mutation in a Chinese hamster ovary cell line transformed to express human O6-alkylguanine-DNA alkyltransferase.
    Minnick DT; Gerson SL; Dumenco LL; Veigl ML; Sedwick WD
    Cancer Res; 1993 Mar; 53(5):997-1003. PubMed ID: 8439973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I clinical trial of O6-benzylguanine and topical carmustine in the treatment of cutaneous T-cell lymphoma, mycosis fungoides type.
    Apisarnthanarax N; Wood GS; Stevens SR; Carlson S; Chan DV; Liu L; Szabo SK; Fu P; Gilliam AC; Gerson SL; Remick SC; Cooper KD
    Arch Dermatol; 2012 May; 148(5):613-20. PubMed ID: 22250189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.